Table 2.

Effectiveness of the needs-tailored nurse-led recovery program

	Descriptive and homogeneity tests				Group effect		Time effect		Group*Time
	Experimental	Control	t	p	F	p	F	p	F	p
Recovery					1.71	0.193	4.42	0.013	5.46	0.005
Pretest	55.95 ± 10.46	56.72 ± 9.23	−0.48	0.631
Post-test	57.40 ± 12.99	54.04 ± 11.36					0.62	0.432	7.04	0.009
Follow-up	59.92 ± 14.35	55.99 ± 10.58					3.96	0.048	8.34	0.004
Empowerment					0.34	0.561	0.13	0.857	0.91	0.397
Pretest	33.49 ± 4.23	33.36 ± 3.24	0.20	0.843
Post-test	33.31 ± 4.67	33.23 ± 3.53					0.33	0.564	0.10	0.922
Follow-up	33.76 ± 5.07	32.96 ± 3.74					0.29	0.864	0.94	0.334
Need					1.44	0.232	88.66	< 0.001	13.91	< 0.001
Pretest	10.78 ± 4.84	9.71 ± 5.97	1.21	0.228
Post-test	6.52 ± 3.50	6.88 ± 3.97					88.43	< 0.001	3.66	0.058
Follow-up	3.95 ± 3.35	6.81 ± 4.95					137.77	< 0.001	22.56	< 0.001
Hope					2.34	0.128	5.22	0.008	4.22	0.019
Pretest	32.30 ± 4.69	32.36 ± 3.67	−0.08	0.933
Post-test	33.66 ± 5.33	32.40 ± 4.03					4.95	0.028	4.42	0.037
Follow-up	34.32 ± 6.00	32.47 ± 4.32					7.41	0.007	5.89	0.016
Medication adherence					8.20	0.005	5.65	0.006	4.73	0.013
Pretest	6.32 ± 2.50	5.92 ± 2.88	0.89	0.375
Post-test	7.26 ± 2.39	5.73 ± 2.83					3.15	0.078	7.20	0.008
Follow-up	7.38 ± 2.20	6.14 ± 2.92					9.47	0.002	4.14	0.044
Psychotic symptoms					2.98	0.086	4.10	0.035	0.43	0.555
Pretest	9.66 ± 8.09	12.51 ± 13.81	−1.56	0.121
Post-test	8.93 ± 7.72	10.46 ± 8.34					2.38	0.125	0.54	0.463
Follow-up	8.07 ± 6.76	9.87 ± 7.53					5.91	0.016	0.37	0.546